Skip to content

Identity, Sterility and Endotoxin Testing

Different tests answer different questions. A result in one category cannot be used as an unreported result in another.

By Peptide Mag Editorial. Updated . Source and review policy.

Build a test-to-question map

A meaningful quality statement names the attribute and the method used to assess it. The following map is a reading aid; it is not a list of tests that every supplier performs or a certificate of suitability for human use.

AttributeQuestion being askedImportant boundary
Molecular identityDoes the measured material match the specified analyte?A shared name alone is insufficient
Purity and impuritiesWhat relevant components can this method distinguish?Method limits and unmeasured components matter
ContentHow much specified analyte is present?Not the same as chromatographic area percentage
Microbiological qualityWhat microbiological test was performed and on what sample?Cannot be read from a chemical purity result
EndotoxinsWas a suitable test performed for the specified material?Not equivalent to sterility
Biological activityDoes the material produce a specified response in an assay?Not automatically a clinical benefit

Why more than one measurement may be needed

Two measurements based on different principles can answer complementary questions. A separation trace and a molecular mass measurement, for instance, should not be described as interchangeable. What matters is the specificity of the actual methods, not the number of logos on a report.

The ICH analytical-validation guideline discusses matching method performance to its purpose. Related biological-product guidance separates identity, purity, potency and quantity. Q6B explicitly excludes synthetic peptides and research materials from its stated scope; its vocabulary must not be misrepresented as a blanket compliance standard for this market.

Respect the sampling boundary

Testing requires a defined submitted sample. The test record should make that identity and the limits of sampling clear. A report does not prove that every item sharing a product name was measured.

If a claimed attribute is not on the report, record it as not reported. Do not translate not reported into passed, failed or safe. This is especially important when a supplier simply says third-party tested without naming the attribute in the same sentence.

A practical review order

Read the sample identity, then each test, result, unit and acceptance criterion. Ask the laboratory or supplier about unresolved method or sample questions. Keep the answers alongside the report so later readers can distinguish documented results from interpretation.

  • Confirm the exact sample and analyte.
  • Separate identity, area purity, content and activity.
  • Check whether microbiological attributes were actually tested.
  • Do not infer a clinical risk-benefit assessment from a laboratory certificate.

Sources and further reading

  1. ICH Q2(R2) — analytical procedure validation
  2. ICH Q6B — biological product specifications; synthetic peptides are outside its stated scope